Literature DB >> 23200827

Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria.

Rajatava Basu1, Darrell B O'Quinn, Daniel J Silberger, Trenton R Schoeb, Lynette Fouser, Wenjun Ouyang, Robin D Hatton, Casey T Weaver.   

Abstract

Interleukin-22 (IL-22) is central to host protection against bacterial infections at barrier sites. Both innate lymphoid cells (ILCs) and T cells produce IL-22. However, the specific contributions of CD4(+) T cells and their developmental origins are unclear. We found that the enteric pathogen Citrobacter rodentium induced sequential waves of IL-22-producing ILCs and CD4(+) T cells that were each critical to host defense during a primary infection. Whereas IL-22 production by ILCs was strictly IL-23 dependent, development of IL-22-producing CD4(+) T cells occurred via an IL-6-dependent mechanism that was augmented by, but not dependent on, IL-23 and was dependent on both transcription factors T-bet and AhR. Transfer of CD4(+) T cells differentiated with IL-6 in the absence of TGF-β ("Th22" cells) conferred complete protection of infected IL-22-deficient mice whereas transferred Th17 cells did not. These findings establish Th22 cells as an important component of mucosal antimicrobial host defense.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200827      PMCID: PMC3678257          DOI: 10.1016/j.immuni.2012.08.024

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  49 in total

1.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen.

Authors:  Lynn Bry; Michael B Brenner
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

Review 3.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

4.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

5.  Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Authors:  Sara Trifari; Charles D Kaplan; Elise H Tran; Natasha K Crellin; Hergen Spits
Journal:  Nat Immunol       Date:  2009-07-05       Impact factor: 25.606

6.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

7.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Authors:  Marina Cella; Anja Fuchs; William Vermi; Fabio Facchetti; Karel Otero; Jochen K M Lennerz; Jason M Doherty; Jason C Mills; Marco Colonna
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

8.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

9.  The AP-1 transcription factor Batf controls T(H)17 differentiation.

Authors:  Barbara U Schraml; Kai Hildner; Wataru Ise; Wan-Ling Lee; Whitney A-E Smith; Ben Solomon; Gurmukh Sahota; Julia Sim; Ryuta Mukasa; Saso Cemerski; Robin D Hatton; Gary D Stormo; Casey T Weaver; John H Russell; Theresa L Murphy; Kenneth M Murphy
Journal:  Nature       Date:  2009-07-05       Impact factor: 49.962

10.  Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.

Authors:  Hiroaki Takatori; Yuka Kanno; Wendy T Watford; Cristina M Tato; Greta Weiss; Ivaylo I Ivanov; Dan R Littman; John J O'Shea
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

View more
  204 in total

1.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Authors:  Shiyang Li; Jennifer J Heller; John W Bostick; Aileen Lee; Hilde Schjerven; Philippe Kastner; Susan Chan; Zongming E Chen; Liang Zhou
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

3.  Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

Authors:  Ju Qiu; Xiaohuan Guo; Zong-Ming E Chen; Lei He; Gregory F Sonnenberg; David Artis; Yang-Xin Fu; Liang Zhou
Journal:  Immunity       Date:  2013-08-15       Impact factor: 31.745

4.  Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.

Authors:  Marcel B M Teunissen; J Marius Munneke; Jochem H Bernink; Phyllis I Spuls; Pieter C M Res; Anje Te Velde; Stanley Cheuk; Marijke W D Brouwer; Stef P Menting; Liv Eidsmo; Hergen Spits; Mette D Hazenberg; Jenny Mjösberg
Journal:  J Invest Dermatol       Date:  2014-03-21       Impact factor: 8.551

5.  IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance.

Authors:  Pei-Yun Tsai; Bingkun Zhang; Wei-Qi He; Juan-Min Zha; Matthew A Odenwald; Gurminder Singh; Atsushi Tamura; Le Shen; Anne Sailer; Sunil Yeruva; Wei-Ting Kuo; Yang-Xin Fu; Sachiko Tsukita; Jerrold R Turner
Journal:  Cell Host Microbe       Date:  2017-06-14       Impact factor: 21.023

6.  Interleukin 1 (IL-1)- and IL-23-mediated expansion of filarial antigen-specific Th17 and Th22 cells in filarial lymphedema.

Authors:  R Anuradha; P Jovvian George; V Chandrasekaran; P Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

7.  IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.

Authors:  Ilona Kryczek; Yanwei Lin; Nisha Nagarsheth; Dongjun Peng; Lili Zhao; Ende Zhao; Linda Vatan; Wojciech Szeliga; Yali Dou; Scott Owens; Witold Zgodzinski; Marek Majewski; Grzegorz Wallner; Jingyuan Fang; Emina Huang; Weiping Zou
Journal:  Immunity       Date:  2014-05-08       Impact factor: 31.745

8.  Leptin receptor signaling in T cells is required for Th17 differentiation.

Authors:  Bernardo S Reis; Kihyun Lee; Melania H Fanok; Cristina Mascaraque; Manal Amoury; Lillian B Cohn; Aneta Rogoz; Olof S Dallner; Pedro M Moraes-Vieira; Ana I Domingos; Daniel Mucida
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Authors:  Michael R Yeaman; Scott G Filler; Siyang Chaili; Kevin Barr; Huiyuan Wang; Deborah Kupferwasser; John P Hennessey; Yue Fu; Clint S Schmidt; John E Edwards; Yan Q Xiong; Ashraf S Ibrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling.

Authors:  Danfeng Sun; Yanwei Lin; Jie Hong; Haoyan Chen; Nisha Nagarsheth; Dongjun Peng; Shuang Wei; Emina Huang; Jingyuan Fang; Ilona Kryczek; Weiping Zou
Journal:  Oncoimmunology       Date:  2015-09-02       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.